Oscar Della Pasqua
Overview
Explore the profile of Oscar Della Pasqua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Healy P, Allegaert K, Della Pasqua O
Br J Clin Pharmacol
. 2024 Oct;
91(2):283-296.
PMID: 39384340
Aims: Our investigation aimed to assess the dose rationale of tramadol in paediatric patients considering the effect of CYP2D6/OCT1 polymorphisms on systemic exposure. Recommendations were made for the oral dose...
2.
DAgate S, Velickovic P, Garcia-Barrios N, Ramon-Garcia S, Della Pasqua O
Br J Clin Pharmacol
. 2024 Sep;
91(1):179-189.
PMID: 39290131
Aims: The current treatment for Buruli ulcer is based on empirical evidence of efficacy. However, there is an opportunity for shortening its duration and improving response rates. Evolving understanding of...
3.
Paggiaro P, Garcia G, Roche N, Verma M, Plank M, Oosterholt S, et al.
Adv Ther
. 2024 Sep;
41(11):4065-4088.
PMID: 39240503
Introduction: Although some factors associated with asthma symptom deterioration and risk of exacerbation have been identified, these are not yet fully characterised. We conducted a clinical modelling and simulation study...
4.
Nardotto G, Svenson E, Bollela V, Rocha A, Slavov S, Ximenez J, et al.
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204315
The present study aims to characterise the pharmacokinetics of rifampicin (RIF) in tuberculosis (TB) patients with and without HIV co-infection, considering the formation of 25-O-desacetyl-rifampicin (desRIF). It is hypothesised that...
5.
Simeoli R, Lava S, Di Deo A, Roversi M, Cairoli S, Tambucci R, et al.
Pharmaceutics
. 2024 Jul;
16(7).
PMID: 39065569
Eosinophilic oesophagitis is a long-term complication of oesophageal atresia (EA), an uncommon condition that affects approximately 1 in 3500 infants. An exploratory, open-label phase 2 clinical trial was conducted in...
6.
Scardovi A, Bartolucci D, Montemurro L, Bortolotti S, Angelucci S, Amadesi C, et al.
Nucleic Acid Ther
. 2024 Jul;
34(4):173-187.
PMID: 38957973
Although has been considered an undruggable target, alterations confer poor prognosis in many pediatric and adult cancers. The novel -specific inhibitor BGA002 is an antigene peptide nucleic acid oligonucleotide covalently...
7.
Fornari C, Arrieta A, Bradley J, Tout M, Magalhaes P, Auriol F, et al.
Br J Clin Pharmacol
. 2024 Jun;
90(10):2597-2610.
PMID: 38925918
Aims: Meropenem/vaborbactam combination is approved in adults by FDA and EMA for complicated urinary tract infections and by EMA also for other Gram-negative infections. We aimed to characterise the pharmacokinetics...
8.
Garcia G, van Dijkman S, Pavord I, Singh D, Oosterholt S, Fulmali S, et al.
Adv Ther
. 2024 Jun;
41(8):3196-3216.
PMID: 38916810
Introduction: The relationship between immediate symptom control, reliever medication use and exacerbation risk on treatment response and factors that modify it have not been assessed in an integrated manner. Here...
9.
Sethi V, Anand C, Della Pasqua O
Pain Ther
. 2024 Apr;
13(3):391-408.
PMID: 38662319
The multifaceted nature of osteoarthritis (OA) pain presents a challenge in understanding and managing the condition. The diverse pain experiences, progression rates, individual responses to treatments, and complex disease mechanisms...
10.
Lava S, Laurence C, Di Deo A, Sekarski N, Burch M, Della Pasqua O
Paediatr Drugs
. 2024 Apr;
26(3):229-243.
PMID: 38635113
Introduction: In adults, sodium-glucose cotransporter type 2 inhibitors have revolutionised the treatment of type 2 diabetes mellitus, heart failure, and chronic kidney disease. Objective: We aimed to review information on...